Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers

Clinical trial NCT04788459 · TERMINATED

Trial details

NCT number: NCT04788459
Sponsor: Takis
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Protection Against COVID-19 and Infections With SARS-CoV- 2 COVID-19 Immunisation

Start date: 2021-02-25
Primary completion: 2021-12-07
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.